Michael David Garrison, Executive Vice President and President of Medical (TASE:PMCN) at Becton Dickinson & Co. (NYSE:BDX), recently sold 597 shares of the company’s common stock. The shares were sold ...

Becton Dickinson's (NYSE:BDX) stock is up by 4.3% over the past month. As most would know, long-term fundamentals ...

Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...

Gateway Investment Advisers LLC reduced its position in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by ...

EVP Shana Carol Neal sold 788 shares of the firm’s stock in a transaction on Tuesday, January 7th. The stock was sold at an ...

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, ...

Compared to the aggregate P/E ratio of the 69.75 in the Health Care Equipment & Supplies industry, Becton Dickinson Inc. has a lower P/E ratio of 40.32. Shareholders might be inclined to think that ...

Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value ... in Franklin Lakes, NJ, Becton, Dickinson and Company, commonly ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.17% of ...

Shares of Becton Dickinson & Co. BDX slumped 0.87% to $226.51 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.07% to ...

Becton Dickinson and Co (BDX) stock saw a decline, ending the day at $232.59 which represents a decrease of $-3.21 or -1.36% from the prior close of $235.8. The stock opened at $237 and touched a low ...

Evercore ISI lowered the firm’s price target on Becton Dickinson (BDX) to $275 from $290 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science ...